कृपया अन्य खोज का प्रयास करें
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Jacqualyn A. Fouse | 61 | 2017 | Chair of the Board of Directors |
Brian M. Goff | 54 | 2022 | CEO & Director |
Kaye I. Foster-Cheek | 63 | 2014 | Lead Independent Director |
Scott A. Biller | 68 | 2010 | Member of Scientific Advisory Board |
Matthew Vander Heiden | - | 2008 | Member of Scientific Advisory Board |
David P. Schenkein | 67 | 2009 | Independent Director |
Marc Tessier-Lavigne | 64 | 2011 | Member of Scientific Advisory Board |
David T. Scadden | 71 | 2017 | Independent Director |
Cynthia Smith | 55 | 2022 | Independent Director |
Maykin Ho | 71 | 2015 | Independent Director |
Charles L. Sawyers | 65 | 2009 | Member of Scientific Advisory Board |
Ralph Deberardinis | - | - | Member of Scientific Advisory Board |
Joan S. Brugge | - | - | Member of Scientific Advisory Board |
Rahul D. Ballal | 46 | 2022 | Independent Director |
Jeffrey D. Capello | 59 | 2023 | Independent Director |
Catherine E. Owen | 53 | 2023 | Independent Director |
Shin-San Su | 68 | - | Co-Founder & Member of Scientific Advisory Board |
Craig B. Thompson | 71 | - | Co-Founder & Chairman of Scientific Advisory Board |
Lewis Clayton Cantley | 75 | 2007 | Co-Founder & Member of Scientific Advisory Board |
Tak Wah Mak | 78 | - | Co-Founder & Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है